Haemostasis in cirrhosis: Understanding destabilising factors during acute decompensation

J Hepatol. 2023 May;78(5):1037-1047. doi: 10.1016/j.jhep.2023.01.010. Epub 2023 Jan 25.

Abstract

Hospitalised patients with decompensated cirrhosis are in a rebalanced haemostatic state due to a parallel decline in both pro- and anti-haemostatic pathways. However, this rebalanced haemostatic state is highly susceptible to perturbations and may easily tilt towards hypocoagulability and bleeding. Acute kidney injury, bacterial infections and sepsis, and progression from acute decompensation to acute-on-chronic liver failure are associated with additional alterations of specific haemostatic pathways and a higher risk of bleeding. Unfortunately, there is no single laboratory method that can accurately stratify an individual patient's bleeding risk and guide pre-procedural prophylaxis. A better understanding of haemostatic alterations during acute illness would lead to more rational and individualised management of hospitalised patients with decompensated cirrhosis. This review will outline the latest findings on haemostatic alterations driven by acute kidney injury, bacterial infections/sepsis, and acute-on-chronic liver failure in these difficult-to-treat patients and provide evidence supporting more tailored management of bleeding risk.

Keywords: bleeding; coagulation; fibrinolysis; platelets; thrombosis.

Publication types

  • Review

MeSH terms

  • Acute Kidney Injury* / complications
  • Acute-On-Chronic Liver Failure* / complications
  • Hemorrhage
  • Hemostasis
  • Hemostatics*
  • Humans
  • Liver Cirrhosis / complications
  • Sepsis* / complications

Substances

  • Hemostatics